Effects of indapamide and various diuretics alone or combined with beta-blockers on serum lipoproteins

References

• Ames R. P., Hill P. Elevation of serum lipid levels during diuretic therapy of hypertension. Am. J. Med. 1976; 61: 748–757
   PubMed Web of Science ®Google Scholar
• Arner P., Oestman J. Importance of the cyclic AMP concentration for the rate of lipolysis in human adipose tissue. Clin. Sci. 1980; 59: 199–201
   PubMed Web of Science ®Google Scholar
• Beevers D. G., Fairman M. J., Hamilton M., Harpur J. E. Antihypertensive treatment and the course of established cerebral vascular disease. Lancet. 1973; 1: 1407–1409
   PubMed Web of Science ®Google Scholar
• Bianchetti M. G., Weidmann P., Gerber A., Ferrier C., Link L., Mordasini R., Riesen W., Bachmann C. Unaltered composition of the serum lipoproteins in men treated short-term with the diuretic-antihypertensive agent indapamide. 1982, In preparation.
   Google Scholar
• Boehringer K., Meier A., Weidmann P., Schiffl H., Mordasini R., Riesen W. Einfluss von Hydrochlorothiazid/Amilorid allein oder in Kombination mit Alpha-Methyldopa auf die Serumlipoproteine. Schweiz. Med. Wochenschr. 1981; 111: 525–530
   PubMedGoogle Scholar
• Boehringer K., Weidmann P., Mordasini R., Schiffl H., Bachmann C., Riesen W. Menopause-dependent plasma lipoprotein alterations in diuretic-treated women. Ann. Intern. Med. 1982; 97: 206–209
   PubMed Web of Science ®Google Scholar
• Castelli W. P., Doyle J. T., Gordon T., Hames C. G., Hjortland M. C., Hulley S G., Kagen A., Zukel W. HDL-cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation. 1977; 55: 767–772
   PubMed Web of Science ®Google Scholar
• Day J. L., Metcalfe J., Simpson N. Adrenergic mechanisms in the control of plasma lipids in man. “Lipoproteins and Coronary Atherosclerosis”, G. Noseda, C. Fragiacomo, R. Fumagalli, R. Paoletti. Elsevier-North Holland, Amsterdam 1982; 355–361
   Google Scholar
• Deacon S. P. The effects of atenolol and propranolol upon lipoproteins. Br. J. Clin. Pharmacol. 1978; 5: 123–125
   PubMed Web of Science ®Google Scholar
• Cluck C. J., Fallat R. W. Secondary hyperliproteinemia: oral contraceptives and pregnancy. “Fettstoffwechsel”, G. Schettler, H. Greten, G. Schlierf, D. Seidel. Springer, Berlin 1976; Vol. 8: 451–458
   Google Scholar
• Glück Z., Baumgartner G., Weidmann P., Peheim E., Bachmann C., Mordasini R., Flammer J., Keusch G. Increased ratio between serum beta and alpha-lipoproteins during diuretic therapy: an adverse effect?. Clin. Sci. 1978; 55: 325s–328s
   Google Scholar
• Cluck Z., Weidmann P., Mordasini R., Peheim E., Bachmann C., Keusch G., Riesen W. Einfluss einer Diuretikatherapie auf Serumlipoproteine: ein unerwünschter Effekt?. Schweiz. Med. Wochenschr. 1979; 109: 104–108
   PubMedGoogle Scholar
• Glück Z., Weidmann P., Mordasini R., Bachmann C., Riesen W., Peheim E., Keusch G., Meier A. Increased serum low-density lipoprotein cholesterol in men treated short-term with the diuretic chlorthalidone. Metabolism. 1980; 29: 240–245
   PubMed Web of Science ®Google Scholar
• Goldman A. I., Steele B. W., Schnaper H W., Fitz A E., Frohlich E. D., Perry H. M., Jr. Serum lipoprotein levels during chlorthalidone therapy. J.A.M.A. 1980; 244: 1961–1965
   Google Scholar
• Grimm R. H., Jr., Leon A. S., Hunninghake D. B., Lenz K., Hannan P., Blackburn H. Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients. Ann. Intern. Med. 1981; 94: 7–11
   PubMed Web of Science ®Google Scholar
• Harms H. H., Gooren L., Spoelstra A. J, G., Hesse C., Verschoor L. Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol. pindolol, practolol, atenolol. metoprolol and acebutolol. Br. J. Clin. Pharmacol. 1978; 5: 19–26
   PubMed Web of Science ®Google Scholar
• Helgeland A., Hjermann I., Leren P., Enger S., Holme I. High density lipoprotein cholesterol and antihypertensive drugs: the Oslo study. Br. Med. J. 1978; 2: 403
   PubMed Web of Science ®Google Scholar
• Helgeland A., Hjermann I., Holme I., Leren P. Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study. Am. J. Med. 1978; 64: 34–38
   PubMed Web of Science ®Google Scholar
• Himms-Hagen I. Effects of catecholamines on metabolism. “Catecholamines. Handbook of Experimental Pharmacology”, H. Blaschko, E. Muscholl. Springer, Berlin, Heidelberg, New York 1972; Vol. 33: 363–462
   Google Scholar
• Hodge J. V., Smirk F. H. The effect of drug treatment of hypertension on the distribution of deaths from various causes. Am. Heart J. 1967; 73: 441–452
   Web of Science ®Google Scholar
• Joos C., Kewitz H., Reinhold-Kouniati D. Effects of diuretics on plasma lipoproteins in healthy men. Eur. J. Clin. Pharmacol. 1980; 17: 251–257
   PubMed Web of Science ®Google Scholar
• Kannel W. B., Castelli W. P., Gordon T. Cholesterol in the prediction of the atherosclerotic disease. New perspectives based on the Framingham study. Ann. Intern. Med. 1979; 90: 85–91
   PubMed Web of Science ®Google Scholar
• Kovanen P. T., Brown M. S., Goldstein J. L. Increased binding of low density lipoprotein to liver membranes from rats treated with 17-alpha-ethinyl estradiol. J. Biol. Chem. 1979; 254: 11367–11373
   PubMed Web of Science ®Google Scholar
• Kovanen P. T., Goldstein J. L., Chappell D. A., Brown M. S. Regulation of low density lipoprotein receptors by adrenocorticotropin in the adrenal gland of mice and rats in vivo. J. Biol. Chem. 1980; 255: 5591–5598
   PubMed Web of Science ®Google Scholar
• Leren P., Foss P. O., Helgeland A., Hjermann I., Holme I., Lund-Larsen P. G. Effect of propranolol and prazosin on blood lipids. The Oslo study. Lancet 1980; 2: 4–6
   PubMed Web of Science ®Google Scholar
• Meier A., Weidmann P., Mordasini R., Riesen W., Bachmann C. Reversal or prevention of diuretic-induced alterations in serum lipoproteins with beta-blockers. Atherosclerosis 1982; 41: 415–419
   PubMed Web of Science ®Google Scholar
• Mordasini R., Glück Z., Weidmann P., Keusch G., Meier A., Riesen W. Zur Pathogenese der Diuretika-induzierten Hyperlipoproteinamie. Klin. Wochenschs 1980; 58: 359–363
   PubMedGoogle Scholar
• Mudge G. H. Diuretics and other agents employed in the mobilisation of edema fluid. “The Pharmacological Basis of Therapeutics” 5th Edit., E. S. Goodman, A. Gilman. Macmillan, New York 1975; 817–847
   Google Scholar
• Sauvanet J. P., Rouffy J. Effets des traitements hypotenseurs sur les lipids et les lipoproteines. Pathol. Biol. 1981; 29: 435–4443
   PubMedGoogle Scholar
• Schiffl H., Weidmann P., Mordasini R., Riesen W., Bachmann C. Reversal of diuretic-induced increases in serum low-density-lipoprotein cholesterol by the beta-blocker pindolol. Metabolism 1982; 31: 411–415
   PubMed Web of Science ®Google Scholar
• Schiffl H., Weidmann P., Mordasini R., Boehringer K., Riesen W., Bachmann C. Serum lipoproteins in patients with renal disease treated with the diuretic muzolimine. Klin. Wochenschr. 1983, In press
   Google Scholar
• Schnaper H., Fitz A., Frohlich E., Goldman A., Perry H. M., Jr. Chlorthalidone and serum cholesterol. Lancet 1977; 2: 295
   PubMed Web of Science ®Google Scholar
• Senft G., Losert W., Schultz G., Sitt R., Bartelheimer H. K. Ursachen und Störungen im Kohlenhydratstoffwechsel unter dem Einfluss sulfonamidierter Diuretika. Naunyn-Schmiedebergs Arch. Pharmacol. Exp. Pathol. 1977; 255: 369–382
   Google Scholar
• McStewart I. D. Compared incidence of first myocardial infarction in hypertensive patients under treatment containing propranolol or excluding beta-receptor blockade. Clin. Sci. 1976; 51: 509s–511s
   Google Scholar
• Van Brummelen P., Gevers Leuven J. A., Van Gent C. M. Influence of hydrochlorothiazide on the plasma levels of triglycerides, total cholesterol and HDL-cholesterol in patients with essential hypertension. Curr. Med. Res. Opin. 1979; 6: 24–29
   PubMed Web of Science ®Google Scholar
• Weidmann P., Meier A., Mordasini R., Riesen W., Bachmann C., Peheim E. Diuretic treatment and serum lipoproteins: effects of tienilic acid and indapamide. Klin. Wochenschs 1981; 59: 343–346
   PubMed Web of Science ®Google Scholar
• Weidmann P., Schiffl H., Mordasini R., Meier A., Boehringer K., Riesen W. Effects of diuretics alone or in combination with beta-blockers on serum lipoproteins. “Lipoproteins and Coronary Atherosclerosis”, G. Noseda, C. Fragiacomo, R. Fumagalli, R. Paoletti. Elsevier Biomedical, Amsterdam 1982; 363–370
   Google Scholar